Denise Boudreau

Denise Boudreau


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2009 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Closed access
PDF file
DBDenise Boudreau
Denise Boudreau
MKMichael Von Korff
Michael Von Korff
CRCarolyn M. Rutter
Carolyn M. Rutter
KSKathleen Saunders
Kathleen Saunders
GRG. Thomas Ray
G. Thomas Ray
CWConstance Weisner
Constance Weisner

9 April 2010 in Expert Opinion on Drug Safety
Verified
Journal Article
Closed access
DBDenise Boudreau
Denise Boudreau
OYOnchee Yu
Onchee Yu
JJJeanene Johnson
Jeanene Johnson
Importance of the field: HMG-CoA inhibitors (statins), a class of drugs that reduce cholesterol, are used to manage and prevent coronary heart disease. They are among the most commonly prescribed d...

21 February 2014 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
DBDenise Boudreau
Denise Boudreau
OYOnchee Yu
Onchee Yu
JCJessica Chubak
Jessica Chubak
HWHeidi S. Wirtz
Heidi S. Wirtz
EBErin J. Aiello Bowles
Erin J. Aiello Bowles
DBDiana S. M. Buist
Diana S. M. Buist

1 February 2004 in American Journal of Epidemiology
Verified
Journal Article
Closed access
DBDenise Boudreau
Denise Boudreau
A validation study evaluated the accuracy of self-reported use of commonly used medications among older women. Within a case-control study of breast cancer, drug information was ascertained by interview. Pharmacy records from 1990 to 1999 were obtained from a Washington State health maintenance organization (66% of subjects) and retail pharmacies (34% of subjects) on a sample of subjects (212 cases, 191 controls) and used as the "gold standard." Recall accuracy was assessed for 6-month, 2-year, and 8-year time windows. Sensitivity of antihypertensive use was 92% (95% confidence interval (CI): 85, 96) for cases and controls in the 6-month period and slightly lower for the 2-year (90% (95% CI: 82, 94) and 87% (95% CI: 78, 92)) and 8-year (80% (95% CI: 69, 88) and 79% (95% CI: 68, 88)) periods. For statins, sensitivity was 83% (95% CI: 64, 93) for cases and 93% (95% CI: 69, 99) for controls in the 6-month period, 75% (95% CI: 55, 88) and 86% (95% CI: 60, 96) in the 2-year period, and 67% (95% CI: 42, 85) and 75% (95% CI: 41, 93) in the 8-year period. For self-report of antidepressants, sensitivities ranged from 66% (95% CI: 47, 80) in the 6-month period to 44% (95% CI: 30, 60) in the 8-year period. Specificity was high among all drug classes, ranging from 91% to 100%. Recall did not differ by case-control status. Trivial changes in estimates were observed when health maintenance organization records alone were used as the gold standard. Self-reported use of antihypertensives and statins appears to be relatively accurate among older women.

26 April 2004 in Cancer
Verified
Journal Article
Closed access
PDF file
DBDenise Boudreau
Denise Boudreau
JGJacqueline S. Gardner
Jacqueline S. Gardner
KMKathleen E. Malone
Kathleen E. Malone
SHSusan R. Heckbert
Susan R. Heckbert
DBDavid K. Blough
David K. Blough
JDJanet R. Daling
Janet R. Daling

1 March 2017 in The American Journal of Medicine
Verified
Journal Article
Closed access
KRKristi Reynolds
Kristi Reynolds
AGAlan S. Go
Alan S. Go
TLThomas K. Leong
Thomas K. Leong
DBDenise Boudreau
Denise Boudreau
ACAndrea E. Cassidy-Bushrow
Andrea E. Cassidy-Bushrow
SSStephen Sidney
Stephen Sidney